Novus Biologicals TACI/TNFRSF13B/CVID Peptide
Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
Manufacturer: Novus Biologicals NBP176779PEP
DescriptionA blocking peptide containing 15 amino amino terminus of human TACI. Source: Synthetic (Accession #: NP_036584) The TACI/TNFRSF13B/CVID Blocking Peptide has been validated for the following applications: Antibody Competition.
|For blocking the activity of TACI, NBP1-76779|
|PBS pH 7.2 (10mM NAH2PO4, 10mM Na2HPO4, 130mM NaCl) containing 0.1% bovine serum albumin.|
|15 amino amino terminus of human TACI|
|−20°C. Avoid freeze-thaw cycles.|